哌嗪-1-乙酸甲酯双盐酸盐

更新时间:2024-01-29 11:36:42

哌嗪-1-乙酸甲酯双盐酸盐结构式
哌嗪-1-乙酸甲酯双盐酸盐结构式
品牌特惠专场
常用名 哌嗪-1-乙酸甲酯双盐酸盐 英文名 1-Piperazineaceticacid,methylester(9CI)
CAS号 82516-17-4 分子量 402.481
密度 1.2±0.1 g/cm3 沸点 528.8±50.0 °C at 760 mmHg
分子式 C23H30O6 熔点 N/A
MSDS N/A 闪点 228.0±30.2 °C

 哌嗪-1-乙酸甲酯双盐酸盐名称

中文名 哌嗪-1-乙酸甲酯双盐酸盐
英文名 piperazin-1-ylmethyl acetate
英文别名 更多

 哌嗪-1-乙酸甲酯双盐酸盐物理化学性质

密度 1.2±0.1 g/cm3
沸点 528.8±50.0 °C at 760 mmHg
分子式 C23H30O6
分子量 402.481
闪点 228.0±30.2 °C
精确质量 402.204254
PSA 41.57000
LogP 4.00
蒸汽压 0.0±1.4 mmHg at 25°C
折射率 1.543

 哌嗪-1-乙酸甲酯双盐酸盐安全信息

海关编码 2933599090

 哌嗪-1-乙酸甲酯双盐酸盐合成线路

~%

哌嗪-1-乙酸甲酯双盐酸盐结构式

哌嗪-1-乙酸甲酯双盐酸盐

82516-17-4

文献:WO2006/62240 A1, ; Page/Page column 575-576 ;

~%

哌嗪-1-乙酸甲酯双盐酸盐结构式

哌嗪-1-乙酸甲酯双盐酸盐

82516-17-4

文献:WO2007/7072 A1, ; Page/Page column 73-74 ; WO 2007/007072 A1

 哌嗪-1-乙酸甲酯双盐酸盐上下游产品

哌嗪-1-乙酸甲酯双盐酸盐上游产品  3

哌嗪-1-乙酸甲酯双盐酸盐下游产品  0

 哌嗪-1-乙酸甲酯双盐酸盐海关

海关编码 2933599090
中文概述 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 哌嗪-1-乙酸甲酯双盐酸盐英文别名

deacetylbowdensine
methyl 2-piperazinoacetate
1-Piperazineaceticacid,methyl ester
1H-4,9a-Ethanocyclohepta[c]pyran-7-carboxylic acid, 3-[(1E,3E)-4-carboxy-1,3-pentadien-1-yl]-3,4,4a,5,6,9-hexahydro-4a-hydroxy-3-methyl-1-oxo-, (3R,4R,4aS,9aR)-
2,4-Pentadienoic acid, 5-[(3R,4R,4aS,9aR)-3,4,4a,5,6,9-hexahydro-4a-hydroxy-3,7-dimethyl-1-oxo-1H-4,9a-ethanocyclohepta[c]pyran-3-yl]-2-methyl-, (2E,4E)-
1-methyloxycarbonylmethylpiperazine
(1R,7S,8R,9R)-9-[(1E,3E)-4-Carboxy-1,3-pentadien-1-yl]-7-hydroxy-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-ene-4-carboxylic acid
2,4-Pentadienoic acid, 5-[(3R,4S,4aS,9aR)-4a-(acetyloxy)-3,4,4a,5,6,9-hexahydro-3,7-dimethyl-1-oxo-1H-4,9a-ethanocyclohepta[c]pyran-3-yl]-2-methyl-, methyl ester, (2E,4E)-
Methyl (1R,7S,8S,9R)-7-acetoxy-9-[(1E,3E)-5-methoxy-4-methyl-5-oxo-1,3-pentadien-1-yl]-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-ene-4-carboxylate
Methyl (2E,4E)-5-[(1R,7S,8S,9R)-7-acetoxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoate
1-Epidideacetylbowdensine
1H-4,9a-Ethanocyclohepta[c]pyran-7-carboxylic acid, 4a-(acetyloxy)-3,4,4a,5,6,9-hexahydro-3-[(1E,3E)-5-methoxy-4-methyl-5-oxo-1,3-pentadien-1-yl]-3-methyl-1-oxo-, methyl ester, (3R,4S,4aS,9aR)-
(2E,4E)-5-[(3R,4R,4aS,9aR)-4a-hydroxy-3,7-dimethyl-1-oxo-3,4,4a,5,6,9-hexahydro-4,9a-ethanocyclohepta[c]pyran-3(1H)-yl]-2-methylpenta-2,4-dienoic acid
Methyl piperazinoacetate
Di-O-deacetyl-1-epibowdensine
Methyl1-piperazineacetate
(2E,4E)-5-[(1R,7S,8R,9R)-7-Hydroxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoic acid
deacetylpseudolaric acid A